Areas of Interest
Antiretroviral therapy, resistance, pharmacology, transmission and HIV persistence and disruption of latency
Dr. Eron is the Principal Investigator of the HIV/AIDS Clinical Research Unit at UNC-CH and the Director of the Clinical Core for the UNC Center for AIDS Research (CFAR). He has been part of the AIDS Clinical Trials Group since 1993 and has held multiple leadership positions including Chair of the Optimization of ART Committee and the Cure Transformative Science Group. He is the Principal Investigator of the UNC Clinical trials Unit with sites in Chapel Hill, Greensboro, Lilongwe Malawi and Hanoi Vietnam. In addition he is a leader of the UNC Acute HIV Infection research team and is a collaborator in the UNC HIV Cure initiative. Over the last 15 years Dr. Eron has led the development of the UNC HIV CFAR Clinic Cohort that includes over 5000 HIV infected individuals and has active collaboration and membership in the NA ACCORD and CNICS cohorts. Dr. Eron has over 400 publications in peer-reviewed journals focusing on antiretroviral therapy, resistance, pharmacology, transmission and HIV persistence and disruption of latency. Recent work has included publications from the UNC CFAR HIV Clinical Cohort, the ACTG, HPTN and IAS-USA HIV treatment guidelines in JAMA 2020. Dr. Eron has worked extensively in the area of HIV drug development and led or participated in original studies of many antiretroviral therapies. He also continues as an active HIV and Infectious Disease clinician. He is now the leader of the ACTG Scientific Agenda Steering Committee and is Vice Chair (co-PI) of the ACTG network.
Education and Training
- Undergraduate Harpur College
- Medical School Harvard Medical School
- Residency Massachusetts General Hospital, Harvard Medical School
- Fellowship Massachusetts General Hospital, Harvard Medical School